Last reviewed · How we verify

CKD-378, QD, PO Drug: D745, D150, QD, PO

Chong Kun Dang Pharmaceutical · Phase 1 active Small molecule

CKD-378, QD, PO Drug: D745, D150, QD, PO is a Small molecule drug developed by Chong Kun Dang Pharmaceutical. It is currently in Phase 1 development. Also known as: CKD-378.

At a glance

Generic nameCKD-378, QD, PO Drug: D745, D150, QD, PO
Also known asCKD-378
SponsorChong Kun Dang Pharmaceutical
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about CKD-378, QD, PO Drug: D745, D150, QD, PO

What is CKD-378, QD, PO Drug: D745, D150, QD, PO?

CKD-378, QD, PO Drug: D745, D150, QD, PO is a Small molecule drug developed by Chong Kun Dang Pharmaceutical.

Who makes CKD-378, QD, PO Drug: D745, D150, QD, PO?

CKD-378, QD, PO Drug: D745, D150, QD, PO is developed by Chong Kun Dang Pharmaceutical (see full Chong Kun Dang Pharmaceutical pipeline at /company/chong-kun-dang-pharmaceutical).

Is CKD-378, QD, PO Drug: D745, D150, QD, PO also known as anything else?

CKD-378, QD, PO Drug: D745, D150, QD, PO is also known as CKD-378.

What development phase is CKD-378, QD, PO Drug: D745, D150, QD, PO in?

CKD-378, QD, PO Drug: D745, D150, QD, PO is in Phase 1.

Related